Abstract
Maternal obesity and nutrient excess in utero increase the risk of future metabolic diseases. The mechanisms underlying this process are poorly understood, but probably include genetic, epigenetic alterations and changes in fetal nutrient supply. We have studied the microRNA (miRNA) expression profile in amnion from obese and control women at delivery to investigate if a specific miRNA signature is associated with obesity. The expression profile of 365 human miRNAs was evaluated with the TaqMan Array in amnion from 10 obese and 5 control (prepregnancy body mass index (BMI) >30 and <25 kg m−2, respectively) women at delivery. Target genes and miRNA-regulated pathways were predicted by bioinformatics. Anthropometric and biochemical parameters were also measured in mothers and newborns. Seven miRNAs were expressed only in obese women (miR-422b, miR-219, miR-575, miR-523, miR-579, miR-618 and miR-659), whereas 13 miRNAs were expressed at a higher level and 12 miRNAs at a lower level in obese women than in controls. MicroRNAs significantly downregulated the neurotrophin, cancer/ErbB, mammalian target of rapamycin, insulin, adipocytokine, actin cytoskeleton and mitogen-activated protein kinase signaling pathways. In conclusion, we show that the miRNA profile is altered in amnion during obesity and hypothesize that this could affect pathways important for placental growth and function, thereby contributing to an increase in the newborn’s risk of future metabolic diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout


Similar content being viewed by others
References
Lillycrop KA, Burdge GC . Epigenetic changes in early life and future risk of obesity. Int J Obes 2011; 35: 72–83.
Heneghan HM, Miller N, Kerin MJ . Role of microRNAs in obesity and the metabolic syndrome. Obes Rev 2010; 11: 354–361.
Pineles BL, Romero R, Montenegro D, Tarca AL, Han YM, Kim YM et al. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol 2007; 196: e1–261.e6.
Yu Z, Han S, Hu P, Zhu C, Wang X, Qian L et al. Potential role of maternal serum microRNAs as a biomarker for fetal congenital heart defects. Med Hypotheses 2011; 76: 424–426.
Martinelli R, Nardelli C, Pilone V, Buonomo T, Liguori R, Castanò I et al. miR-519d overexpression is associated with human obesity. Obesity (Silver Spring, MD) 2010; 18: 2170–2176.
Capobianco V, Nardelli C, Ferrigno M, Iaffaldano L, Pilone V, Forestieri P et al. miRNA and protein expression profiles of visceral adipose tissue reveal miR-141/YWHAG and miR-520e/RAB11A as two potential miRNA/protein target pairs associated with severe obesity. J Proteome Res 2012; 11: 3358–3369.
Fowden AL, Forhead AJ, Coan PM, Burton GJ . The placenta and intrauterine programming. J Neuroendocrinol 2008; 20: 439–450.
Hawkins SM, Creighton CJ, Han DY, Zariff A, Anderson ML, Gunaratne PH et al. Functional microRNA involved in endometriosis. Mol Endocrinol 2011; 25: 821–832.
Mayor-Lynn K, Toloubeydokhti T, Cruz AC, Chegini N . Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reprod Sci 2011; 18: 46–56.
Yang Q, Lu J, Wang S, Li H, Ge Q, Lu Z . Application of next-generation sequencing technology to profile the circulating microRNAs in the serum of preeclampsia versus normal pregnant women. Clin Chim Acta 2011; 412: 2167–2173.
Lee CH, Subramanian S, Beck AH, Espinosa I, Senz J, Zhu SX et al. MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary. PLoS One 2009; 4: e7314.
Li H, Guo L, Wu Q, Lu J, Ge Q, Lu Z . A comprehensive survey of maternal plasma miRNAs expression profiles using high-throughput sequencing. Clin Chim Acta 2012; 413: 568–576.
Kotlabova K, Doucha J, Hromadnikova I . Placental-specific microRNA in maternal circulation—identification of appropriate pregnancy-associated microRNAs with diagnostic potential. J Reprod Immunol 2011; 89: 185–191.
Mayeur S, Silhol M, Moitrot E, Barbaux S, Breton C, Gabory A et al. Placental BDNF/TrkB signaling system is modulated by fetal growth disturbances in rat and human. Placenta 2010; 31: 785–791.
Jansson T, ILMH Aye, DCI Goberdhan . The emerging role of mTORC1 signaling in placental nutrient-sensing. Placenta 2012; 33 (Suppl 2): e23–e29.
Jones KT, Greer ER, Pearce D, Ashrafi K . Rictor/TORC2 regulates Caenorhabditis elegans fat storage, body size, and development through sgk-1. PLoS Biol 2009; 7: e60.
Jacinto E, Loewith R, Schmidt A, Lin S, Rüegg MA, Hall A et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 2004; 6: 1122–1128.
Ihnatovych I, Livak M, Reed J, de Lanerolle P, Strakova Z . Manipulating actin dynamics affects human in vitro decidualization. Biol Reprod 2009; 81: 222–230.
Kang JH, Song H, Yoon JA, Park DY, Kim SH, Lee KJ et al. Preeclampsia leads to dysregulation of various signaling pathways in placenta. J Hypertens 2011; 29: 928–936.
Palin MF, Bordignon VV, Murphy BD . Adiponectin and the control of female reproductive functions. Vitam Horm 2012; 90: 239–287.
Acknowledgements
This work was supported by grants from CEINGE Regione Campania (DGRC 1901/2009), IRCCS Fondazione SDN, Ministry of Health and POR Campania FSE 2007–2013 and Project CREME. We thank Jean Ann Gilder (Scientific Communication srl, Naples, Italy) for revising and editing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Nardelli, C., Iaffaldano, L., Ferrigno, M. et al. Characterization and predicted role of the microRNA expression profile in amnion from obese pregnant women. Int J Obes 38, 466–469 (2014). https://doi.org/10.1038/ijo.2013.121
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ijo.2013.121
Keywords
This article is cited by
-
Maternal obesity alters C19MC microRNAs expression profile in fetal umbilical cord blood
Nutrition & Metabolism (2020)
-
Elafin inhibits obesity, hyperglycemia, and liver steatosis in high-fat diet-treated male mice
Scientific Reports (2020)
-
Transcriptome analysis of miRNA and mRNA in the livers of pigs with highly diverged backfat thickness
Scientific Reports (2019)
-
MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics
International Journal of Obesity (2016)
-
Proteome analysis of human amniotic mesenchymal stem cells (hA-MSCs) reveals impaired antioxidant ability, cytoskeleton and metabolic functionality in maternal obesity
Scientific Reports (2016)


